Shoulder Innovations (NYS: SI) key facts
- Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market.
- Shoulder Innovations (NYS: SI)’s last known valuation is $303.4M (Jul 2025).
- It has raised $231.2M; the latest was IPO ($75.0M) in Jul 2025.
- Notable investors include Gilde Healthcare, Trinity Capital Inc BDC, Cultivate(MD), U.S. Venture Partners.
- 4 institutional filers report fund marks on Shoulder Innovations (NYS: SI) across 43 filings.
- Status: Publicly Held.
Who backs Shoulder Innovations (NYS: SI)
4- ·Watch Shoulder Innovations (NYS: SI): the Monday email on marks, rounds and moves
Shoulder Innovations (NYS: SI) funding rounds
No funding rounds for Shoulder Innovations (NYS: SI) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Shoulder Innovations (NYS: SI) valuation
Shoulder Innovations (NYS: SI) is now publicly traded; this page covers its private-market history, where its last recorded valuation was $303 million (Jul 2025). Secondary trades, fund marks and rounds below are the private-market record; the listed share price is not tracked here.
Recent activity
In the last 90 days, Shoulder Innovations (NYS: SI)'s record added 3 institutional fund marks (latest period Jul 2026).
Institutional holders and vehicles
4 SEC-registered funds reported 43 fair-value marks on Shoulder Innovations (NYS: SI) between Jul 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
Shoulder Innovations (NYS: SI) investors
4 investors are on record for Shoulder Innovations (NYS: SI), including Gilde Healthcare, Trinity Capital Inc BDC, Cultivate(MD) and U.S. Venture Partners.
About Shoulder Innovations (NYS: SI)
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
- Sector
- Healthcare
- HQ
- Holland, MI, United States
- Founded
- 2009
- Employees
- 75
- Website
- shoulderinnovations.com/
- Ownership
- Publicly Held
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Shoulder Innovations (NYS: SI)’s last known valuation, Jul 2025. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.
Institutional fund marks on Shoulder Innovations (NYS: SI)
4 filers · latest Jul 20264 SEC-registered funds reported 43 fair-value marks on Shoulder Innovations (NYS: SI) between Jul 2025 and Jul 2026. Filer-level marks and implied $/share are available to Pro members.
Membership and data by Private Market View